Trials / Completed
CompletedNCT00256139
CLEAR Study: Clinical Experience Acquired With Raptiva Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 793 (actual)
- Sponsor
- Merck KGaA, Darmstadt, Germany · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- —
Summary
A multicentre, randomised, double blind, placebo controlled phase III study of subcutaneously administered Raptiva in the treatment of patients with moderate to severe psoriasis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Raptiva |
Timeline
- Start date
- 2003-03-01
- Primary completion
- 2004-10-01
- Completion
- 2004-10-01
- First posted
- 2005-11-21
- Last updated
- 2017-01-16
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT00256139. Inclusion in this directory is not an endorsement.